# EDGAR Filing Document

**Accession Number:** 0002112995
**File Stem:** 0001213900-26-060059
**Filing Date:** 2026-5
**Character Count:** 13934
**Document Hash:** 6ee2b6840b7e7f5d60cfbf046ec54d8b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-060059.hdr.sgml**: 20260521

**ACCESSION NUMBER**: 0001213900-26-060059

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260521

**DATE AS OF CHANGE**: 20260521

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Universe Pharmaceuticals INC
- **CENTRAL INDEX KEY:** 0001809616
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** F4
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-93205
- **FILM NUMBER:** 261008649

**BUSINESS ADDRESS:**
- **STREET 1:** 265 JINGJIU AVENUE
- **STREET 2:** JINGGANGSHAN ECON. AND TECH. DEV. ZONE
- **CITY:** JI'AN, JIANGXI
- **STATE:** F4
- **ZIP:** 343100
- **BUSINESS PHONE:** 86-0796-8403309

**MAIL ADDRESS:**
- **STREET 1:** 265 JINGJIU AVENUE
- **STREET 2:** JINGGANGSHAN ECON. AND TECH. DEV. ZONE
- **CITY:** JI'AN, JIANGXI
- **STATE:** F4
- **ZIP:** 343100
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Lai Gang
- **CENTRAL INDEX KEY:** 0002112995

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 265 JINGJIU AVENUE
- **STREET 2:** JINGGANGSHAN ECON. AND TECH. DEV. ZONE
- **CITY:** JI'AN
- **NON US STATE TERRITORY:** JIANGXI
- **PROVINCE COUNTRY:** F4
- **ZIP:** 343100

## Exhibit 99.1

**Exhibit 99.1**

**<u>JOINT FILING AGREEMENT</u>**

In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13D referred to below) on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the Class A ordinary shares, par value US$0.00001 per share, of Universe Pharmaceuticals INC, a Cayman Islands company, and that this Agreement may be included as an exhibit to such joint filing. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

IN WITNESS WHEREOF, the undersigned hereby execute this Agreement as of May 21, 2026.

---

| | |
|:---|:---|
| **Sununion Holding Group Limited** | **Sununion Holding Group Limited** |
| /s/ Gang Lai | /s/ Gang Lai |
| Name: | Gang Lai |
| Title: | Director |
| /s/ Gang Lai | /s/ Gang Lai |
| Name: | Gang Lai |

---

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**Universe Pharmaceuticals INC**

*(Name of Issuer)*

**Class A ordinary shares, par value US$0.00001 per share**

*(Title of Class of Securities)*

**—**

*(CUSIP Number)*

**GANG LAI**<br>265 Jingjiu Avenue<br>Jinggangshan Econ. and Tech. Dev. Zone<br>Ji'an, Jiangxi F4 343100<br>86-0796-8403309

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**05/07/2026**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Sununion Holding Group Ltd** | Name of reporting person<br>**Sununion Holding Group Ltd** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**D8** | Citizenship or place of organization<br>**D8** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**3467.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**3467.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**3467.00** | Aggregate amount beneficially owned by each reporting person<br>**3467.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0.55%** | Percent of class represented by amount in Row (11)<br>**0.55%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**CO** | Type of Reporting Person (See Instructions)<br>**CO** | |

---

**Comment for Reporting Person:** The amount in rows 8, 10 and 11 represents 3,467 Class A ordinary shares issuable upon the conversion of 3,467 Class B ordinary shares beneficially owned by Mr. Gang Lai through Sununion Holding Group Limited, a business company incorporated in the British Virgin Islands, which is controlled by Mr. Gang Lai.

The beneficial ownership percentage set forth in row 13 is calculated based on 631,761 Class A ordinary shares of the Issuer issued and outstanding as of the date of this filing, plus 3,467 Class A ordinary shares issuable upon the conversion of 3,467 Class B ordinary shares beneficially owned by Mr. Gang Lai through Sununion Holding Group Limited.

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Gang Lai** | Name of reporting person<br>**Gang Lai** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**CHINA** | Citizenship or place of organization<br>**CHINA** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**84500.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**3467.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**84500.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**3467.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**87967.00** | Aggregate amount beneficially owned by each reporting person<br>**87967.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**13.58%** | Percent of class represented by amount in Row (11)<br>**13.58%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Comment for Reporting Person:** The amount in rows 7 and 9 represents 71,890 Class A ordinary shares directly owned by Mr. Gang Lai and 12,610 Class A ordinary shares issuable upon the conversion of 12,610 Class B ordinary shares directly owned by Mr. Gang Lai.

The amount in rows 8 and 10 represents 3,467 Class A ordinary shares issuable upon the conversion of 3,467 Class B ordinary shares beneficially owned by Mr. Gang Lai through Sununion Holding Group Limited, a business company incorporated in the British Virgin Islands, which is controlled by Mr. Gang Lai.

The amount in row 11 represents 71,890 Class A ordinary shares directly owned by Mr. Gang Lai, 12,610 Class A ordinary shares issuable upon the conversion of 12,610 Class B ordinary shares directly owned by Mr. Gang Lai, and 3,467 Class A ordinary shares issuable upon the conversion of 3,467 Class B ordinary shares beneficially owned by Mr. Gang Lai through Sununion Holding Group Limited, a business company incorporated in the British Virgin Islands, which is controlled by Mr. Gang Lai.

The beneficial ownership percentage set forth in row 13 is calculated based on 631,761 Class A ordinary shares of the Issuer issued and outstanding as of the date of this filing, plus 16,077 Class A ordinary shares issuable upon the conversion of 16,077 Class B ordinary shares directly owned by Mr. Gang Lai and beneficially owned by Mr. Gang Lai through Sununion Holding Group Limited.

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Class A ordinary shares, par value US$0.00001 per share

**(b) Name of Issuer:**
Universe Pharmaceuticals INC

**(c) Address of Issuer's Principal Executive Offices:**
265 Jingjiu Avenue, Jinggangshan Economic and Technological, Ji'an, Jiangxi, F4, 343100

**Item 4. Purpose of Transaction**

Gang Lai serves as Chief Executive Officer and Chairman of the Board of Directors of the Issuer. In such capacities, Gang Lai may engage in communications with the Issuer's Board of Directors, members of management, other shareholders, financial and legal advisers, and other parties regarding the Issuer, including but not limited to the Issuer's operations, governance and control. In addition, in these capacities, he may have influence over the corporate activities of the Issuer, including activities which may relate to items described in subparagraphs (a) through (j) of Item 4 of Schedule 13D. Except as set forth herein, Gang Lai does not have any plans or proposals which relate to, or could result in, any of the matters referred to in paragraphs (a) through (j), inclusive, of the instructions to Item 4 of Schedule 13D. He may, at any time and from time to time, review or reconsider his position and/or change his purpose and/or formulate plans or proposals with respect thereto.

Gang Lai acquired the ordinary shares pursuant to the Equity Grant and intends to maintain his holding in the Issuer on a continuing basis. Nevertheless, he may acquire additional shares of the Issuer or sell or otherwise dispose of any or all of the shares that he beneficially owns.

**Item 5. Interest in Securities of the Issuer**

**(a)**
Sununion Holding Group Limited beneficially owns 3,467 Class B ordinary shares, which represents 0.55% of the Issuer's outstanding Class A ordinary shares as of the date of this filing. Gang Lai, who is the control person of Sununion Holding Group Limited, may be deemed to beneficially own the ordinary shares held by Sununion Holding Group Limited. In addition, Gang Lai directly owns 71,890 Class A ordinary shares and 12,610 Class B ordinary shares. Gang Lai therefore beneficially owns 87,967 ordinary shares (consisting of 71,890 Class A ordinary shares and 16,077 Class B ordinary shares), which represents 13.58% of the Issuer's outstanding Class A ordinary shares as of the date of this filing. The percentage of beneficial ownership of the Reporting Persons, as reported in this Schedule 13D, was calculated by dividing (i) the total number of Class A ordinary shares beneficially owned by each Reporting Person as set forth in this Schedule 13D by (ii) the sum of 631,761 Class A ordinary shares outstanding as of the date of this filing and the number of Class A ordinary shares issuable upon the conversion of any securities convertible into Class A ordinary shares within 60 days from the date of this filing.

**(b)**
Gang Lai has sole voting and sole dispositive power over the 71,890 Class A ordinary shares and 12,610 Class B ordinary shares he directly holds. He has shared voting and shared dispositive power over the 3,467 Class B ordinary shares held through Sununion Holding Group Limited. Sununion Holding Group Limited has shared voting power and shared dispositive power over the 3,467 Class B ordinary shares it directly holds.

**(c)**
To the best knowledge of the Reporting Persons, except as disclosed in this Schedule 13D, none of the Reporting Persons has effected any transactions relating to the Class A ordinary shares during the past 60 days.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

The information set forth in Item 4 of this Schedule 13D is hereby incorporated by reference into this Item 6, as applicable. Other than the foregoing agreements and arrangements and the Joint Filing Agreement, there are no contracts, arrangements, understandings or relationships among the persons named in Item 2 hereof and between such persons and any person with respect to any securities of the Issuer.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Sununion Holding Group Ltd

**Signature:** /s/ Gang Lai

**Name/Title:** Gang Lai / Director

**Date:** 05/21/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Gang Lai

**Signature:** /s/ Gang Lai

**Name/Title:** Gang Lai

**Date:** 05/21/2026